Sanofi (BKK:SANOFI80)

Marinus Pharmaceuticals Statistics

Total Valuation

Sanofi has a market cap or net worth of THB 3.74 trillion. The enterprise value is 4.01 trillion.

Market Cap	3.74T
Enterprise Value	4.01T

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	May 13, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.95%
Shares Change (QoQ)	-1.36%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.10B

Valuation Ratios

The trailing PE ratio is 10.76 and the forward PE ratio is 10.02.

PE Ratio	10.76
Forward PE	10.02
PS Ratio	2.15
PB Ratio	1.40
P/TBV Ratio	5.66
P/FCF Ratio	10.31
P/OCF Ratio	8.75
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.53, with an EV/FCF ratio of 11.06.

EV / Earnings	11.53
EV / Sales	2.34
EV / EBITDA	8.53
EV / EBIT	11.23
EV / FCF	11.06

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.

Current Ratio	1.27
Quick Ratio	0.81
Debt / Equity	0.32
Debt / EBITDA	1.80
Debt / FCF	2.34
Interest Coverage	16.85

Financial Efficiency

Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.20%.

Return on Equity (ROE)	9.00%
Return on Assets (ROA)	4.60%
Return on Invested Capital (ROIC)	6.20%
Return on Capital Employed (ROCE)	9.78%
Revenue Per Employee	21.05M
Profits Per Employee	4.20M
Employee Count	82,878
Asset Turnover	0.36
Inventory Turnover	1.30

Taxes

In the past 12 months, Sanofi has paid 58.59 billion in taxes.

Income Tax	58.59B
Effective Tax Rate	19.24%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.21
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.81
Average Volume (20 Days)	142,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of THB 1.74 trillion and earned 348.08 billion in profits. Earnings per share was 280.83.

Revenue	1.74T
Gross Profit	1.24T
Operating Income	357.88B
Pretax Income	304.56B
Net Income	348.08B
EBITDA	460.83B
EBIT	357.88B
Earnings Per Share (EPS)	280.83

Balance Sheet

The company has 585.82 billion in cash and 849.98 billion in debt, giving a net cash position of -264.17 billion.

Cash & Cash Equivalents	585.82B
Total Debt	849.98B
Net Cash	-264.17B
Net Cash Per Share	n/a
Equity (Book Value)	2.68T
Book Value Per Share	2,193.92
Working Capital	303.53B

Cash Flow

In the last 12 months, operating cash flow was 427.72 billion and capital expenditures -64.69 billion, giving a free cash flow of 363.03 billion.

Operating Cash Flow	427.72B
Capital Expenditures	-64.69B
Free Cash Flow	363.03B
FCF Per Share	n/a

Margins

Gross margin is 71.32%, with operating and profit margins of 20.51% and 19.95%.

Gross Margin	71.32%
Operating Margin	20.51%
Pretax Margin	17.46%
Profit Margin	19.95%
EBITDA Margin	26.42%
EBIT Margin	20.51%
FCF Margin	20.81%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 3.48%.

Dividend Per Share	0.10
Dividend Yield	3.48%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	52.29%
Buyback Yield	0.95%
Shareholder Yield	4.42%
Earnings Yield	9.30%
FCF Yield	9.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6